Marker Therapeutics Announces Board Resignation
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Wall St set for lower open as AI jitters rekindle, oil gains
- Brent hits five-month high on escalating Middle East conflict
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- JPMorgan says AI stock selling may be nearing its limit as positioning resets
Tweet
Share
E-mailHouston-based biopharmaceutical company Marker Therapeutics, Inc., with a market capitalization of $20.45 million, reported a change in its board composition earlier this week. On Thursday, the firm announced the resignation of Mr. John Wilson from its Board of Directors, effective January 24, 2025. The details surrounding Mr. Wilson's departure have not been disclosed, and the company has not named a successor at this time.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Sweetgreen names former Shake Shack culinary exec as new chef
- Terra Innovatum advances NRC permit filing and reactor procurement
- IBM and Scuderia Ferrari HP add AI features to fan mobile app
Create E-mail Alert Related Categories
Board ChangesRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
